Zogenix, Inc. Financials

Market Capitalization $1.49 Billion as of March 1, 2022

Valuations Metrics as of Jan. 25, 2025

Trailing PE
Forward PE	-9.77
Price to Sales TTM	$23.49
Price to Book MRQ	$6.65
Enterprise to Revenue	11.97
Enterprise to EBITDA	-3.64

Financial Reports as of Dec. 31, 2021

Financials

Fiscal Year Ends	2020-12-31
Most Recent Quarter	2021-12-31
Profit Margin	94.08%
Operating Margin	-343.93%
Return on Assets TTM	-22.99%
Return on Equity TTM	-75.09%

Income Statement

Revenue TTM	$63,584,000
Revenue per Share TTM	$1.14
Quarterly Revenue Growth	690.60%
Gross Profit TTM	$-124,901,000
EBITDA	$-209,231,008
Net Income to Common TTM	$-242,700,000
Diluted EPS TTM	$-4.35
Quarterly Earnings Growth YoY	212.96%

Balance Sheet

Total Cash MRQ	$343,024,000
Total Cash per Share MRQ	$6.13
Total Debt MRQ	$
Total Debt to Equity MRQ	74.27
Current Ratio MRQ	4.79
Book Value per Share MRQ	$4.01

Cash Flow

Operating Cash Flow TTM	$-182,324,992
Levered Free Cash Flow TTM	$-96,607,752

ZGNX Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	55,992,100
Float Shares	49,178,969
Avg 10 Volume	3,364,635
Avg 30 Volume	None
Shares Short	5,890,086
Short Ratio	9.14
Short % of Shares	10.57%
% Held by Insiders	0.68%
% Held by Institutions	107.24%

Stock Price Summary

Beta	1.18
Fifty Two Week Low	$11.03
Fifty Two Week High	$26.90
Fifty Two Week Change	%
Day 50 MA	$23.18
Day 200 MA	$17.40

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$
Trailing Annual Dividend Yield	%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date	2015-07-01